NCT01410435View on ClinicalTrials.gov

Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease

PHASE3CompletedINTERVENTIONAL

Enrollment

39

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

September 30, 2013

Conditions

Inflammatory Bowel DiseaseAnaemia

Interventions

DRUG

Monofer

Infusion according to current HB level

Trial Locations (2)

Unknown

Austria, Austria

Hungary, Hungary

Sponsors

Lead Sponsor

Pharmacosmos A/S

All Listed Sponsors

lead

Pharmacosmos A/S

INDUSTRY